Roles of the serotonin 5-HT4 receptor in dendrite formation of the rat hippocampal neurons in vitro

Brain Res. 2017 Jan 15:1655:114-121. doi: 10.1016/j.brainres.2016.11.021. Epub 2016 Nov 25.

Abstract

Serotonin (5-HT) is involved in various aspects of hippocampal development, although the specific roles of 5-HT receptors are poorly understood. We investigated the roles of 5-HT receptors in the dendrite formation of hippocampal neurons. We focused on the 5-HT4 receptor, which is coupled with Gs protein, and compared the effects with those of the Gi-coupled 5-HT1A receptor. Neurons from rat hippocampi at embryonic day 18 were dissociated and treated for 4 days with the 5-HT4 receptor agonist BIMU8 or the 5-HT1A receptor agonist 8-OH DPAT. The formation of primary dendrites and dendrite branching were promoted by BIMU8, whereas the dendrite branching was inhibited by 8-OH DPAT. BIMU8-induced promotion of dendrite formation was neutralized by concomitant treatment with the 5-HT4 receptor antagonist, confirming the specific actions of the 5-HT4 receptor. We then examined the signaling mechanisms underlying the actions of the 5-HT4 receptor by using a protein kinase A (PKA) inhibitor. The BIMU8-induced promotion of dendrite formation was reversed partially by the PKA inhibitor, suggesting involvement of PKA signaling downstream of the 5-HT4 receptor. Finally, we examined the contribution of brain-derived neurotrophic factor (BDNF) to the promotion of dendrite formation by BIMU8. Quantitative RT-PCR analysis showed that BIMU8 increased the BDNF mRNA expression and that treatment of cultured neurons with the TrkB antagonist reversed the BIMU8-induced increase in dendrite formation. In summary, the present study suggests a novel role for the 5-HT4 receptor in facilitation of dendrite formation in which intracellular signaling of PKA and the BDNF-TrkB system may be involved.

Keywords: Dendrite formation; Dissociated cell culture; Hippocampus; Serotonin; Serotonin 4 receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8-Hydroxy-2-(di-n-propylamino)tetralin / pharmacology
  • Animals
  • Benzimidazoles / pharmacology
  • Brain-Derived Neurotrophic Factor / metabolism
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology
  • Cells, Cultured
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Dendrites / drug effects
  • Dendrites / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Immunohistochemistry
  • Neuronal Outgrowth / drug effects
  • Neuronal Outgrowth / physiology
  • RNA, Messenger / metabolism
  • Rats, Wistar
  • Receptor, Serotonin, 5-HT1A / metabolism
  • Receptor, trkB / antagonists & inhibitors
  • Receptor, trkB / metabolism
  • Receptors, Serotonin, 5-HT4 / metabolism*
  • Serotonin 5-HT1 Receptor Agonists / pharmacology
  • Serotonin 5-HT4 Receptor Agonists / pharmacology
  • Serotonin 5-HT4 Receptor Antagonists / pharmacology

Substances

  • Benzimidazoles
  • Brain-Derived Neurotrophic Factor
  • Bridged Bicyclo Compounds, Heterocyclic
  • Enzyme Inhibitors
  • RNA, Messenger
  • Serotonin 5-HT1 Receptor Agonists
  • Serotonin 5-HT4 Receptor Agonists
  • Serotonin 5-HT4 Receptor Antagonists
  • Receptor, Serotonin, 5-HT1A
  • (endo-N-8-methyl-8-azabicyclo-(3.2.1)oct-3-yl)-2,3-dihydro-3-isopropyl-2-oxo-1H-benzimidazol-1-carboxamide
  • Receptors, Serotonin, 5-HT4
  • 8-Hydroxy-2-(di-n-propylamino)tetralin
  • Receptor, trkB
  • Cyclic AMP-Dependent Protein Kinases